Cardiometabolic Risk: Characteristics of the Intestinal Microbiome and the Role of Polyphenols

Cardiometabolic diseases like hypertension, type 2 diabetes mellitus, atherosclerosis, and obesity have been associated with changes in the gut microbiota structure, or dysbiosis. The beneficial effect of polyphenols on reducing incidence this chronic disease has confirmed by numerous studies. Polyphenols are primarily known for their anti-inflammatory antioxidant properties, but they can also modify microbiota. According to recent research, positively influence microbiota, which regulates metabolic responses reduces systemic inflammation. This review emphasizes prebiotic role impact specific components patients at cardiometabolic risk. It analyzes most research positive effects health. While vitro vivo studies shown interaction involving additional clinical investigations required assess people.